TY - JOUR
T1 - Candida tropicalis vertebral osteomyelitis
T2 - a late sequela of fungemia
AU - Ferra, Christelle
AU - Doebbeling, Bradley N.
AU - Hollis, Richard J.
AU - Pfaller, Michael A.
AU - Lee, Choon Kee
AU - Gingrich, Roger D.
PY - 1994/10
Y1 - 1994/10
N2 - Two adult patients who had undergone bone marrow transplantation had transientfungemia due to Candida tropicalis during the posttransplantation neutropenic period and later (at 5 and 14 months post-transplantation) developed vertebral osteomyelitis dueto the same organism. The courses of all adult patients who underwent bone marrow transplantation at our center during this time were reviewed for determining the frequency of this problem. Molecular typing techniques were used to establish the relationship between the organisms isolated during the initial fungemia and those causing the subsequent osteomyelitis. Only two of 532 adults who received transplants at our center from 1980 to 1993 developed candidal osteomyelitis. Moreover, they are part of a subset of 13 patients (2.4% of the total) whose cultures were positive for C. tropicalis; fiveof the13 had fungemia. The study of fungal isolates from prior sites of colonization and fromblood sampled during the original fungemia and of subsequently recovered vertebral boneisolates by means of DNA restriction fragment analysis (with use of standard agarose gel electrophoresis or pulsed-field gel electrophoresis) showed that the colonizing, bloodstream, and bone isolates were identical in each case. Transient C. tropicalis fungemia in severely immunocompromised patients may cause important late infectious complications, including osteomyelitis. Although these initial septic events may appear toresolve easily, the outcome in the two cases in this report suggests that special treatment considerations, such as immediate removal of the central venous catheter and intensive treatment with amphotericin B, may be required in selected cases for prevention oflate sequelae.
AB - Two adult patients who had undergone bone marrow transplantation had transientfungemia due to Candida tropicalis during the posttransplantation neutropenic period and later (at 5 and 14 months post-transplantation) developed vertebral osteomyelitis dueto the same organism. The courses of all adult patients who underwent bone marrow transplantation at our center during this time were reviewed for determining the frequency of this problem. Molecular typing techniques were used to establish the relationship between the organisms isolated during the initial fungemia and those causing the subsequent osteomyelitis. Only two of 532 adults who received transplants at our center from 1980 to 1993 developed candidal osteomyelitis. Moreover, they are part of a subset of 13 patients (2.4% of the total) whose cultures were positive for C. tropicalis; fiveof the13 had fungemia. The study of fungal isolates from prior sites of colonization and fromblood sampled during the original fungemia and of subsequently recovered vertebral boneisolates by means of DNA restriction fragment analysis (with use of standard agarose gel electrophoresis or pulsed-field gel electrophoresis) showed that the colonizing, bloodstream, and bone isolates were identical in each case. Transient C. tropicalis fungemia in severely immunocompromised patients may cause important late infectious complications, including osteomyelitis. Although these initial septic events may appear toresolve easily, the outcome in the two cases in this report suggests that special treatment considerations, such as immediate removal of the central venous catheter and intensive treatment with amphotericin B, may be required in selected cases for prevention oflate sequelae.
UR - http://www.scopus.com/inward/record.url?scp=0028092721&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0028092721&partnerID=8YFLogxK
U2 - 10.1093/clinids/19.4.697
DO - 10.1093/clinids/19.4.697
M3 - Article
C2 - 7803635
AN - SCOPUS:0028092721
SN - 1058-4838
VL - 19
SP - 697
EP - 703
JO - Clinical Infectious Diseases
JF - Clinical Infectious Diseases
IS - 4
ER -